Type 1 spinal muscular atrophy treated with nusinersen in Norway, a five-year follow-up
Eur J Paediatr Neurol, 53, 109-116 (in press)
DOI 10.1016/j.ejpn.2024.09.009, PubMed 39447351
Aberrations in medically certified sick leave and primary healthcare consultations in Norway in 2023 compared to pre-COVID-19-pandemic trends
Arch Public Health, 82 (1), 187
DOI 10.1186/s13690-024-01411-4, PubMed 39438966
Speed of processing training to improve cognition in moderate to severe TBI: a randomized clinical trial
Front Neurol, 15, 1445560
DOI 10.3389/fneur.2024.1445560, PubMed 39268073